Kiersten Stead, Co-Founder and Managing Partner of DCVC Bio sits down with Neil to discuss her firm’s approach to deep tech investing in biotech, her focus on platform technologies, and how to separate what’s real from what’s hype in AI

Bioverge
The Bioverge newsletter focuses on investing at the intersection of health + tech.
Topics range from the macro to the micro and novel technologies, interspaced with our own personal musings.
The Bioverge newsletter focuses on investing at the intersection of health + tech.
Topics range from the macro to the micro and novel technologies, interspaced with our own personal musings.Listen on
Substack App
RSS Feed
Recent Episodes
Share this post